News
News Releases
FRONTEO and Axcelead DDP Sign Master Collaboration Agreement for AI Drug Discovery Support Partnership
FRONTEO Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Masahiro Morimoto; hereinafter “FRONTEO”) and Axcelead Drug Discovery Partners...
Axcelead DDP’s Drug Discovery Support Business Honored with the 6th Japan Medical Research and Development Grand Prize
Axcelead Drug Discovery Partners Inc. (“Axcelead DDP”) is pleased to announce that it has been honored with...
Discussions Begin on Collaborative Genomic Drug Discovery Support Using the IQVIA Genome Wide Study Platform
Axcelead Drug Discovery Partners Inc. (Headquarters: Fujisawa, Kanagawa; President and CEO: Nobuhiko Yamada; hereinafter, “Axcelead DDP”) and...
BIO International Convention 2023: Meet us in Boston
Axcelead will be exhibiting at upcoming BIO International Convention 2023 in Boston. Visit us at Japan Pavilion...
Luncheon seminar at the 43rd Workshop of the Korean Society of Nonclinical Study
Join us for our luncheon seminar and visit us at booth #8 during the 43rd Workshop of...